Endpoints
Efficacy endpoint was freedom from AF or other supraventricular arrhythmias (lasting >30 seconds) at 1-year follow-up. Because early recurrences of AF may be a transient phenomenon, a 3-months blanking period was used. Safety endpoints were incidence of mortality, morbidity or other procedure-related complications.